Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia

A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one month later. However, he soon developed purpura in his lower limbs...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shintaro Sato, Moegi Kurachi, Hiroki Ohta, Tomohiko Nakamura, Tomohiro Oba, Rie Kawabe, Hideaki Yamakawa, Masako Amano, Hidekazu Matsushima
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	COVID-19 Diffuse alveolar hemorrhage Immune thrombocytopenia Purpura Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/f607decf60a040aaba9f87a3f54f22f4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f607decf60a040aaba9f87a3f54f22f4
record_format	dspace
spelling	oai:doaj.org-article:f607decf60a040aaba9f87a3f54f22f42021-12-04T04:33:58ZDelayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia2213-007110.1016/j.rmcr.2021.101563https://doaj.org/article/f607decf60a040aaba9f87a3f54f22f42021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2213007121002252https://doaj.org/toc/2213-0071A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one month later. However, he soon developed purpura in his lower limbs and thrombocytopenia, and immune thrombocytopenia was subsequently diagnosed. Although immune thrombocytopenia is one of the early complications of COVID-19, the use of corticosteroids for COVID-19 is thought to be a factor in the late onset of immune thrombocytopenia. In cases of severe COVID-19 for which corticosteroids were used for treatment, autoimmune diseases such as immune thrombocytopenia may manifest themselves late in the disease course.Shintaro SatoMoegi KurachiHiroki OhtaTomohiko NakamuraTomohiro ObaRie KawabeHideaki YamakawaMasako AmanoHidekazu MatsushimaElsevierarticleCOVID-19Diffuse alveolar hemorrhageImmune thrombocytopeniaPurpuraDiseases of the respiratory systemRC705-779ENRespiratory Medicine Case Reports, Vol 34, Iss , Pp 101563- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 Diffuse alveolar hemorrhage Immune thrombocytopenia Purpura Diseases of the respiratory system RC705-779
spellingShingle	COVID-19 Diffuse alveolar hemorrhage Immune thrombocytopenia Purpura Diseases of the respiratory system RC705-779 Shintaro Sato Moegi Kurachi Hiroki Ohta Tomohiko Nakamura Tomohiro Oba Rie Kawabe Hideaki Yamakawa Masako Amano Hidekazu Matsushima Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
description	A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one month later. However, he soon developed purpura in his lower limbs and thrombocytopenia, and immune thrombocytopenia was subsequently diagnosed. Although immune thrombocytopenia is one of the early complications of COVID-19, the use of corticosteroids for COVID-19 is thought to be a factor in the late onset of immune thrombocytopenia. In cases of severe COVID-19 for which corticosteroids were used for treatment, autoimmune diseases such as immune thrombocytopenia may manifest themselves late in the disease course.
format	article
author	Shintaro Sato Moegi Kurachi Hiroki Ohta Tomohiko Nakamura Tomohiro Oba Rie Kawabe Hideaki Yamakawa Masako Amano Hidekazu Matsushima
author_facet	Shintaro Sato Moegi Kurachi Hiroki Ohta Tomohiko Nakamura Tomohiro Oba Rie Kawabe Hideaki Yamakawa Masako Amano Hidekazu Matsushima
author_sort	Shintaro Sato
title	Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
title_short	Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
title_full	Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
title_fullStr	Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
title_full_unstemmed	Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
title_sort	delayed onset of severe immune thrombocytopenia associated with covid-19 pneumonia
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/f607decf60a040aaba9f87a3f54f22f4
work_keys_str_mv	AT shintarosato delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT moegikurachi delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT hirokiohta delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT tomohikonakamura delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT tomohirooba delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT riekawabe delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT hideakiyamakawa delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT masakoamano delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia AT hidekazumatsushima delayedonsetofsevereimmunethrombocytopeniaassociatedwithcovid19pneumonia
_version_	1718373007292891136

Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia

Ejemplares similares